Callan Family Office’s Entegris ENTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
6,869
-610
-8% -$88K 0.02% 541
2026
Q1
$877K Buy
7,479
+922
+14% +$109K 0.02% 599
2025
Q4
$552K Buy
6,557
+1,434
+28% +$125K 0.01% 755
2025
Q3
$474K Sell
5,123
-3,434
-40% -$292K 0.02% 549
2025
Q2
$690K Buy
8,557
+5,818
+212% +$442K 0.02% 487
2025
Q1
$240K Sell
2,739
-368
-12% -$37.1K 0.02% 483
2024
Q4
$308K Buy
+3,107
New +$328K 0.02% 470

Other funds holding ENTG

Callan Family Office's ENTG Position: Q2 2026 in Review

Callan Family Office reduced its Entegris (ENTG) stake by 8.2% in Q2 2026, selling an estimated $88K and leaving 6,869 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #541.

Callan Family Office first reported a position in ENTG in Q4 2024 and has held it in 7 quarters since. 743 funds tracked by Wall St. Rank hold ENTG as of Q2 2026.

  • Callan Family Office held 6,869 shares of Entegris worth $1.24M as of Q2 2026.
  • Callan Family Office sold 610 Entegris shares in Q2 2026, an estimated $88K.
  • Entegris made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #541 holding.
  • Callan Family Office first reported a position in Entegris in Q4 2024 and has held it in 7 quarters since.
  • 743 funds tracked by Wall St. Rank held Entegris as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.